Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study
Frank T. Kolligs(Helios Hospital Berlin-Buch), Alessandro Vit(Azienda Ospedaliera S.Maria), Roberto Cioni, Thomas Pfammatter(University Hospital of Zurich), Bleranda Zeka(Cardiovascular and Interventional Radiological Society of Europe), Murat Özgün(University of Münster), Allan Bloom, Thomas Helmberger(München Klinik Bogenhausen), Niels de Jong(FWF Austrian Science Fund), Axel Schmid(Universitätsklinikum Erlangen), Maciej Pech(University Hospital Magdeburg), Rita Golfieri(University of Bologna), Dirk Arnold(Asklepios Klinik Altona), Sadık Bilgiç(Ankara University), Graham Munneke(University College London Hospitals NHS Foundation Trust), Niklaus Schaefer(University Hospital of Bern), Laurent Gérard, Christiane Kühl(Universitätsklinikum Aachen), Gerd Grözinger, Geert Maleux(Universitair Ziekenhuis Leuven), Patrick Flamen(Université Libre de Bruxelles), Roman Fischbach(Asklepios Klinik Altona), Héléna Pereira(Inserm), Bruno Sangro(Clinica Universidad de Navarra), Franco Orsi, Maxime Ronot(Hôpital Beaujon), Bora Peynırcıoğlu(Hacettepe University), Jan Robert Kröger, Peter Reimer(Essen University Hospital), Michael Koehler, O d'Archambeau, Tuğsan Ballı, Marcus Katoh, Thomas Albrecht(Roche (Switzerland))
Cited by 46
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k
Mammography, Breast Ultrasound, and Magnetic Resonance Imaging for Surveillance of Women at High Familial Risk for Breast Cancer
|Journal of Clinical Oncology|2005|1.1k